North China Pharmaceutical Co (600812.SS) Stock Price
North China Pharmaceutical Co Price
Over the last 19 years North China Pharmaceutical Co grew revenue by 4.5% annually, reaching 9.24 B CNY. Earnings per share have grown at 3.4% per year over the last 18 years. For North China Pharmaceutical Co, the net margin of 2.0% is up versus 0.2% a few years ago. At today's price the dividend yield works out to roughly 0.71%. The payout ratio is around 28% of earnings.
North China Pharmaceutical Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
North China Pharmaceutical Co business model & stock analysis
Frequently asked questions about North China Pharmaceutical Co
6 analysts currently rate the North China Pharmaceutical Co stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect North China Pharmaceutical Co to generate revenue of 11.09 B CNY and earnings per share of 0.16 CNY.
Converted at the current exchange rate, the North China Pharmaceutical Co share trades at 0.58 EUR (4.23 CNY).
The North China Pharmaceutical Co share (600812.SS) is listed on 1 stock exchanges, including: Shanghai (600812.SS).
The expected revenue of North China Pharmaceutical Co is 11.09 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of North China Pharmaceutical Co is 274.52 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of North China Pharmaceutical Co is currently 26.44. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the North China Pharmaceutical Co stock.
The price-to-sales ratio (P/S) of North China Pharmaceutical Co is currently 0.65. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the North China Pharmaceutical Co stock.
The Eulerpool Quality Score for North China Pharmaceutical Co is 4/10.
The ISIN of North China Pharmaceutical Co is CNE000000D16. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of North China Pharmaceutical Co is 600812.SS. The ticker symbol is used to trade North China Pharmaceutical Co shares on the stock exchange.
North China Pharmaceutical Co stock
North China Pharmaceutical Co Peer Group
North China Pharmaceutical Co Ticker
North China Pharmaceutical Co FIGI
All fundamentals and in-depth analysis of North China Pharmaceutical Co
Our stock analysis for North China Pharmaceutical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of North China Pharmaceutical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.